To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
NCT ID: NCT02213120
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2014-08-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease
NCT05355610
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
NCT04674735
Evaluation of Vestibular Function in Patients With C.S.O.M: Safe Type
NCT04791930
Audiovestibular Function in Infratentorial Superficial Siderosis
NCT04200664
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
NCT06001593
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dizziness
Patients with Dizziness
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with vestibular vertigo of known or unknown origin
* Patients who are willing and able to provide written informed consent
Exclusion Criteria
* Patient with psychiatric disorders, significant neurological disorder or spinal cord damage that would make the evaluation difficult for the investigator
* Patients who are not willing to give informed consent
* Patients with a known history of hypersensitivity to betahistine
* Patients with a history of pheochromocytoma
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dimension Research
INDUSTRY
Abbott
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raeefuddin Ahmed, MD
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research facility ID ORG-001139
Hyderābād, , Pakistan
Research facility ID ORG-001053
Islamabad, , Pakistan
Research facility ID ORG-001070
Karachi, , Pakistan
Research facility ID ORG-001051
Karachi, , Pakistan
Research facility ID ORG-001069
Karachi, , Pakistan
Research facility ID ORG-001050
Karachi, , Pakistan
Research facility ID ORG-001060
Lahore, , Pakistan
Research facility ID ORG-001054
Lahore, , Pakistan
Research facility ID ORG-001055
Lahore, , Pakistan
Research facility ID ORG-001061
Lahore, , Pakistan
Research facility ID ORG-001052
Peshawar, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BETA5003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.